HER2 overexpression is found in a significant percentage of certain types of cancer, most notably breast cancer and gastric cancer. In these cancers, HER2-positive status is associated with a more aggressive disease course and a poorer prognosis. HER2-positive breast cancer accounts for approximately 20-25% of all breast cancer cases.
